Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Screening and Detection, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, and Global Cancer Incidence and Screening.
Looking at randomized trials with the critical eyes of epidemiologists: the case of screening colonoscopy
Accounting for differential exclusions in the Nordic-European initiative on colorectal cancer trial discloses stronger-than-reported effects of screening colonoscopy
Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials
Potential for enhancing efficacy of screening colonoscopy by lowering starting ages and extending screening intervals: A modelling study for Germany
Dollars Needed to Pay per Early-Detected Colorectal Cancer Case in Stool-Based Screening
Fecal occult blood tests for colorectal cancer screening in routine medical care
Effects of Screening Colonoscopy: Evidence From Observational and Interventional Studies
Early-detection and prevention effects of screening sigmoidoscopy: evidence from randomized trials revisited
Contributions of early detection and cancer prevention to colorectal cancer mortality reduction by screening colonoscopy: a validated modeling study
Delayed Cancer Registration and Estimation of Screening Colonoscopy Effects
Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening
Unraveling the effects of screening colonoscopy on colorectal cancer early detection and prevention: the NordICC trial revisited
The underestimated preventive effects of flexible sigmoidoscopy screening: re-analysis and meta-analysis of randomized trials
Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the <scp>COVID‐19</scp> pandemic
Disclosing the true impact of screening endoscopy in colorectal cancer prevention
Colorectal cancer: A health and economic problem
Reduction in colorectal cancer incidence by screening endoscopy
Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
Colonoscopy-Ascertained Prevalence of Advanced Neoplasia According to Fecal Hemoglobin Concentration in a Large Cohort of Fecal Immunochemical Test–Negative Screening Participants
Overall and age‐specific risk advancement periods of colorectal cancer for men vs women: Implications for gender‐sensitive screening offers?
Significant underestimation of preventive effects in colorectal cancer screening trial
Which results would the NordICC trial have found if screening colonoscopy had prevented all incident colorectal cancers?
Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality
Using risk advancement periods to derive starting ages of colorectal cancer screening according to sex and polygenic risk score: Results from the UK Biobank
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries
Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study
Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study